Skip to main content

Table 1 Prevalence of stimulant use among Flemish students 1965-2005

From: Stimulant medication use among Flemish students: results from an exploring secondary data analysis1965-2005

Study Prové & Varenne
(1965)
Van de Voorde et al. (1967-1968) Waege et al.
(1993)
Waege et al.
(1993)
Rosiers & Van Hal (2005) Rosiers & Van Hal (2005)
Number of respondents (n = 1,848) (n = 6,982) (n = 1,936) (n = 2,007) (n = 1,501) (n = 1,501)
Male/Female M: 83.7%
F: 16.3%
M: 77.1%
F: 22.9%
M: 50.9%/F: 49,1% M: 46.9%/F: 53.1%
Residential/
commuter
R: 46.3%
C: 53.7%
R: 81.4%
C: 18.6%
R: 81.6%
C: 18.4%
R: 29.0%/C: 71.0%
Reference period Exams Last year Exams Pre-exams Exams Last year
Prevalence (%) 5.7% 5.7% 9.5% 3.6% 2.6% 2.9%
Numbers of stimulant users (n = 106) (n = 395) (n = 183) (n = 73) (n = 39) (n = 44)
Gender: ns ns ns - - **
Male (%) 5.4% 5.9% 8.9%    4.3%
Female (%) 7.6% 4.7% 10.4%    1.8%
Level of
significance
p = 0.12 p = 0.07 p = 0.27 - - p = 0.004
Living status: ** * *** - - *
Residential (%) 7.6% 6.0% 13.2%    4.7%
Commuter (%) 4.1% 4.3% 5.6%    2.4%
Level of significance p = 0.001 p = 0.04 p < 0.001 - - p = 0.04
Most popular products Rilatine® (38.7%) Rilatine® (35.4%) Catovit®(80%)
Captagon® (14%)
-
  1. *** p < 0.001
  2. ** p < 0.01
  3. * p < 0.05
  4. ns not significant (p ≥ 0.05)